BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12796803)

  • 1. Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness.
    Culligan DJ; Salamat A; Tait J; Westland G; Watson HG
    Bone Marrow Transplant; 2003 Jun; 31(12):1183-4. PubMed ID: 12796803
    [No Abstract]   [Full Text] [Related]  

  • 2. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
    De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
    Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia].
    Zotz RB; Scharf RE
    Hamostaseologie; 2007 Sep; 27(4):251-62. PubMed ID: 17938763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uncontrollable bleeding in a patient with head trauma treated with blood component therapy guided by thromboelastography].
    Hansen MK; Jensen MK; Andersen C
    Ugeskr Laeger; 2006 Oct; 168(41):3535-6. PubMed ID: 17059810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIIa for bleeding in refractory thrombocytopenia.
    Vidarsson B; Onundarson PT
    Thromb Haemost; 2000 Apr; 83(4):634-5. PubMed ID: 10780334
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIIa in severe uremic bleeding.
    Révész T; Arets B; Bierings M; van den Bos C; Duval E
    Thromb Haemost; 1998 Aug; 80(2):353. PubMed ID: 9716175
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of traumatic bleeding with recombinant factor VIIa.
    Kenet G; Walden R; Eldad A; Martinowitz U
    Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
    Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of life-threatening bleeding in obstetrics and gynaecology --NovoSeven (recombinant factor VIIa)].
    Nikolov A; Dimitrov A; Tanchev S; Platikanov V; Nacheva A; Gateva Zh; Gerganova A
    Akush Ginekol (Sofiia); 2005; 44(5):39-44. PubMed ID: 16313053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
    Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
    von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bleeding associated with septic shock treated successfully with recombinant activated factor VII: a case report].
    Del Cojo Peces E; Torrado Criado MD; Macías Pingarrón JP; Negrete Calderón N
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):301-3. PubMed ID: 15968911
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage.
    Duffy MR
    Int J Obstet Anesth; 2007 Jul; 16(3):299-300; author reply 300. PubMed ID: 17509865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.